{"id":"https://openalex.org/W4362638121","doi":"https://doi.org/10.1158/1535-7163.22519552","title":"Figure S1 from Site-Specific PEGylation of Anti-Mesothelin Recombinant Immunotoxins Increases Half-life and Antitumor Activity","display_name":"Figure S1 from Site-Specific PEGylation of Anti-Mesothelin Recombinant Immunotoxins Increases Half-life and Antitumor Activity","publication_year":2023,"publication_date":"2023-04-03","ids":{"openalex":"https://openalex.org/W4362638121","doi":"https://doi.org/10.1158/1535-7163.22519552"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.22519552","doi":"https://doi.org/10.1158/1535-7163.22519552","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.22519552","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1535-7163.22519552","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5069928382","display_name":"Zeliang Zheng","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Zeliang Zheng","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042339519","display_name":"Ryuhei Okada","orcid":"https://orcid.org/0000-0003-3589-5054","observed_orcids":["https://orcid.org/0000-0003-3589-5054"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ryuhei Okada","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-3589-5054","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090173640","display_name":"Hisataka Kobayashi","orcid":"https://orcid.org/0000-0003-1019-4112","observed_orcids":["https://orcid.org/0000-0003-1019-4112"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hisataka Kobayashi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075595526","display_name":"Tadanobu Nagaya","orcid":"https://orcid.org/0000-0002-0091-8343","observed_orcids":["https://orcid.org/0000-0002-0091-8343"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tadanobu Nagaya","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005008349","display_name":"Junxia Wei","orcid":"https://orcid.org/0009-0009-8366-4657","observed_orcids":["https://orcid.org/0009-0009-8366-4657"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Junxia Wei","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Qi Zhou","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Qi Zhou","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101398908","display_name":"Fred Lee","orcid":"https://orcid.org/0000-0003-1275-5497","observed_orcids":["https://orcid.org/0000-0003-1275-5497"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Fred Lee","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002583441","display_name":"Tapan Kumar Bera","orcid":"https://orcid.org/0000-0002-8779-4004","observed_orcids":["https://orcid.org/0000-0002-8779-4004"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tapan K. Bera","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015906742","display_name":"Yun Liang Gao","orcid":"https://orcid.org/0000-0002-9898-5690","observed_orcids":["https://orcid.org/0000-0002-9898-5690","https://orcid.org/0000-0002-9694-0907","https://orcid.org/0000-0002-3012-0340"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yun Gao","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052483257","display_name":"William A. Kuhlman","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"William Kuhlman","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076748687","display_name":"Chin\u2010Hsien Tai","orcid":"https://orcid.org/0000-0003-4766-0535","observed_orcids":["https://orcid.org/0000-0003-4766-0535"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Chin-Hsien Tai","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5056573254","display_name":"Ira H Pastan","orcid":"https://orcid.org/0000-0002-9223-0270","observed_orcids":["https://orcid.org/0000-0002-9223-0270"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ira Pastan","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-9223-0270","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12477","display_name":"Toxin Mechanisms and Immunotoxins","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12477","display_name":"Toxin Mechanisms and Immunotoxins","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pegylation","display_name":"PEGylation","score":0.875},{"id":"https://openalex.org/keywords/recombinant-immunotoxin","display_name":"recombinant immunotoxin","score":0.9599999785423279},{"id":"https://openalex.org/keywords/mesothelin","display_name":"mesothelin","score":0.7200000286102295},{"id":"https://openalex.org/keywords/half-life","display_name":"half-life","score":0.4620000123977661},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.9929999709129333}],"concepts":[{"id":"https://openalex.org/C115085202","wikidata":"https://www.wikidata.org/wiki/Q425665","display_name":"Immunotoxin","level":4,"score":0.9243816137313843},{"id":"https://openalex.org/C2779149719","wikidata":"https://www.wikidata.org/wiki/Q682252","display_name":"PEGylation","level":3,"score":0.9184091091156006},{"id":"https://openalex.org/C2777045440","wikidata":"https://www.wikidata.org/wiki/Q14914057","display_name":"Mesothelin","level":3,"score":0.863174319267273},{"id":"https://openalex.org/C40767141","wikidata":"https://www.wikidata.org/wiki/Q285697","display_name":"Recombinant DNA","level":3,"score":0.7538154721260071},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.47935420274734497},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.47858214378356934},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3799976706504822},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.304014652967453},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.250440776348114},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.1984889805316925},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.186446875333786},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.1114819347858429},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.10183358192443848},{"id":"https://openalex.org/C2776964284","wikidata":"https://www.wikidata.org/wiki/Q410083","display_name":"Polyethylene glycol","level":2,"score":0.08039021492004395}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1535-7163.22519552","doi":"https://doi.org/10.1158/1535-7163.22519552","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.22519552","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1535-7163.22519552","doi":"https://doi.org/10.1158/1535-7163.22519552","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.22519552","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4362638274","https://openalex.org/W4362624793","https://openalex.org/W4362624998","https://openalex.org/W4362637515","https://openalex.org/W4392701640","https://openalex.org/W4362635872","https://openalex.org/W2020169547","https://openalex.org/W1990761369","https://openalex.org/W4392687717","https://openalex.org/W2132214488"],"abstract_inverted_index":{"Cell":[0],"Killing":[1],"Activities":[2],"of":[3],"control":[4],"RIT":[5]},"counts_by_year":[],"updated_date":"2026-10-06T10:28:23.643775","created_date":"2023-04-07T00:00:00"}